Evidence map›Paper›PMID 18677115›Full record

ArticleCell cycle (Georgetown, Tex.)2008

Aurora kinase A controls meiosis I progression in mouse oocytes.

Adela Saskova, Petr Solc, Vladimir Baran, Michal Kubelka, Richard M Schultz, Jan Motlik

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Temporally distinct roles of Aurora A in polarization of thebioRxiv : the preprint server for biology · 2023
    Article
  6. Article
  7. Regulation of oocyte maturation: Role of conserved ERK signaling.Molecular reproduction and development · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Adela SaskovaInstitute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov, Czech Republic.
Petr Solc
Vladimir Baran
Michal Kubelka
Richard M Schultz
Jan Motlik
Czech Academy of Sciences, Institute of Animal Physiology and Genetics · CZ

Funding

PROTEIN PHOSPHORYLATION IN PREIMPLANTATION DEVELOPMENTR01HD022681 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI SCHULTZ, RICHARD MORRIS · 1987 to 2017
$3.6M
GENE EXPRESSION IN THE PREIMPLANTATION EMBRYOR37HD022681 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI SCHULTZ, RICHARD M · 1997 to 2006
$2.2M
NICHD NIH HHS R01 HD022681NICHD NIH HHS R37 HD022681
6 · The paper itself

Abstract

Aurora kinase A (AURKA), which is a centrosome-localized serine/threonine kinase crucial for cell cycle control, is critically involved in centrosome maturation and spindle assembly in somatic cells. Active T288 phosphorylated AURKA localizes to the centrosome in the late G(2) and also spreads to the minus ends of mitotic spindle microtubules. AURKA activates centrosomal CDC25B and recruits cyclin B1 to centrosomes. We report here functions for AURKA in meiotic maturation of mouse oocytes, which is a model system to study the G(2) to M transition. Whereas AURKA is present throughout the entire GV-stage oocyte with a clear accumulation on microtubule organizing centers (MTOC), active AURKA becomes entirely localized to MTOCs shortly before germinal vesicle breakdown. In contrast to somatic cells in which active AURKA is present at the centrosomes and minus ends of microtubules, active AURKA is mainly located on MTOCs at metaphase I (MI) in oocytes. Inhibitor studies using Roscovitine (CDK1 inhibitor), LY-294002 (PI3K inhibitor) and SH-6 (PKB inhibitor) reveal that activation of AURKA localized on MTOCs is independent on PI3K-PKB and CDK1 signaling pathways and MOTC amplification is observed in roscovitine- and SH-6-treated oocytes that fail to undergo nuclear envelope breakdown. Moreover, microinjection of Aurka mRNA into GV-stage oocytes cultured in 3-isobutyl-1-methyl xanthine (IBMX)-containing medium to prevent maturation also results in MOTC amplification in the absence of CDK1 activation. Overexpression of AURKA also leads to formation of an abnormal MI spindle, whereas RNAi-mediated reduction of AURKA interferes with resumption of meiosis and spindle assembly. Results of these experiments indicate that AURKA is a critical MTOC-associated component involved in resumption of meiosis, MTOC multiplication, proper spindle formation and the metaphase I-metaphase II transition.

Indexed as

AnimalsAurora Kinase AAurora KinasesBlastodiscCell CycleCyclin-Dependent KinasesFemaleHeLa CellsHumansMeiosisMiceMice, Inbred BALB CMice, Inbred C57BLMicrotubule-Organizing CenterNIH 3T3 CellsOocytesAURKA protein, humanAurka protein, mouseAurora Kinase AAurora KinasesCyclin-Dependent KinasesPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID18677115
PMCPMC3191911
OpenAlexW1993800044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.